Allstate Corp <ALL.N>: Mizuho raises target price to $300 from $272
ALL•Related News
Faeth Therapeutics presents PK/PD modeling supporting PIKTOR dose in Phase 2 endometrial cancer trial FTH-PIK-201
FTH•
BTQ Technologies, ITRI complete first QCIM post-quantum cryptography chip milestone in multiyear collaboration
BTQ•
Zoetis Inc. <ZTS.N>: Morgan Stanley Cuts Target Price to $85.00 From $99.00
ZTS•
Twilio Inc <TWLO.N>: Morgan Stanley Raises Target Price to $261.00 From $200.00
TWLO•
Microchip Technology <MCHP.O>: Truist Securities cuts target price to $90 from $105
MCHP•